tiprankstipranks
Trending News
More News >
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market

Citius Pharmaceuticals (CTXR) Technical Analysis

Compare
1,690 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Citius Pharmaceuticals’s (CTXR) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Citius Pharmaceuticals is a Sell.
Citius Pharmaceuticals’s (CTXR) 20-Day exponential moving average is 0.80, while Citius Pharmaceuticals’s (CTXR) share price is $0.85, making it a Buy.
Citius Pharmaceuticals’s (CTXR) 50-Day exponential moving average is 1.03, while Citius Pharmaceuticals’s (CTXR) share price is $0.85, making it a Sell.

Citius Pharmaceuticals (CTXR) Pivot Points

Jun 08, 2025, 12:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.68
0.74
0.80
0.86
0.92
0.98
1.04
Fibonacci
0.74
0.79
0.81
0.86
0.91
0.93
0.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Pharmaceuticals (CTXR) Moving Averages

Jun 08, 2025, 12:53 PM
Period
Simple
Exponential
MA5
0.84Buy
0.83Buy
MA10
0.77Buy
0.80Buy
MA20
0.78Buy
0.80Buy
MA50
0.89Sell
1.03Sell
MA100
1.57Sell
2.16Sell
MA200
5.06Sell
6.05Sell
Citius Pharmaceuticals’s (CTXR) 10-Day exponential moving average is 0.80, while Citius Pharmaceuticals’s (CTXR) share price is $0.85, making it a Buy.
Citius Pharmaceuticals’s (CTXR) 100-Day exponential moving average is 2.16, while Citius Pharmaceuticals’s (CTXR) share price is $0.85, making it a Sell.
Citius Pharmaceuticals’s (CTXR) stock price is $0.85 and Citius Pharmaceuticals’s (CTXR) 50-day simple moving average is 0.89, creating a Sell signal.
Citius Pharmaceuticals’s (CTXR) stock price is $0.85 and Citius Pharmaceuticals’s (CTXR) 100-day simple moving average is 1.57, creating a Sell signal.
Citius Pharmaceuticals’s (CTXR) stock price is $0.85 and Citius Pharmaceuticals’s (CTXR) 200-day simple moving average is 5.06, creating a Sell signal.

Citius Pharmaceuticals (CTXR) Technical Indicators

Jun 08, 2025, 12:53 PM
Name
Value
Implied Action
RSI (14)
52.71
Neutral
STOCH (9,6)
69.09
Neutral
STOCHRSI (14)
69.42
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
13.45
Buy
Williams %R
-34.17
Buy
CCI (14)
72.93
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
54.04
Neutral
ROC
0.00
Buy
Citius Pharmaceuticals’s (CTXR) Relative Strength Index (RSI) is 52.71, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Trend Strength Indicator (ADX) is 13.45, creating a Buy signal.
Citius Pharmaceuticals’s (CTXR) Commodity Channel Index (CCI) is 72.93, creating a Neutral signal.

FAQ

Is CTXR a Buy, Hold, or Sell?
Based on CTXR’s technical indicators, CTXR is a Hold.
    What is CTXR’s RSI (14)?
    CTXR’s RSI (14) is 52.71, which suggests CTXR is a Neutral.
      What is CTXR’s MACD?
      CTXR’s MACD is -0.02, which suggests CTXR is a Sell.
        What is CTXR’s 5-day moving average?
        CTXR’s 5-day moving average is 0.84, which suggests CTXR is a Buy.
          What is CTXR’s 20-day moving average?
          CTXR 20-day moving average is 0.78, which suggests CTXR is a Buy.
            What is CTXR’s 50-day moving average?
            CTXR’s 50-day moving average is 0.89, which suggests CTXR is a Sell.
              What is CTXR’s 200-day moving average?
              CTXR’s 200-day moving average is 5.06, which suggests CTXR is a Sell.
                What is CTXR’s Williams % R (14)?
                CTXR’s Williams % R (14) is -34.17, which suggests CTXR is a Buy.
                  What is CTXR’s CCI (14)?
                  CTXR’s CCI (14) is 72.93, which suggests CTXR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis